DNLI logo

Denali Therapeutics (DNLI) Working capital

annual working capital:

$762.23M-$223.93M(-22.71%)
December 31, 2024

Summary

  • As of today (June 17, 2025), DNLI annual working capital is $762.23 million, with the most recent change of -$223.93 million (-22.71%) on December 31, 2024.
  • During the last 3 years, DNLI annual working capital has risen by +$243.24 million (+46.87%).
  • DNLI annual working capital is now -46.47% below its all-time high of $1.42 billion, reached on December 31, 2020.

Performance

DNLI Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIbalance sheet metrics

quarterly working capital:

$786.76M+$24.53M(+3.22%)
March 31, 2025

Summary

  • As of today (June 17, 2025), DNLI quarterly working capital is $786.76 million, with the most recent change of +$24.53 million (+3.22%) on March 31, 2025.
  • Over the past year, DNLI quarterly working capital has dropped by -$104.23 million (-11.70%).
  • DNLI quarterly working capital is now -44.75% below its all-time high of $1.42 billion, reached on December 31, 2020.

Performance

DNLI quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

DNLI Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-22.7%-11.7%
3 y3 years+46.9%+21.6%
5 y5 years+98.1%+41.2%

DNLI Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-24.4%+46.9%-31.9%+21.6%
5 y5-year-46.5%+98.1%-44.8%+57.1%
alltimeall time-46.5%+2445.0%-44.8%+355.2%

DNLI Working capital History

DateAnnualQuarterly
Mar 2025
-
$786.76M(+3.2%)
Dec 2024
$762.23M(-22.7%)
$762.23M(-2.5%)
Sep 2024
-
$781.75M(-8.4%)
Jun 2024
-
$853.85M(-4.2%)
Mar 2024
-
$890.99M(-9.6%)
Dec 2023
$986.15M(-2.2%)
$986.15M(-8.0%)
Sep 2023
-
$1.07B(-7.2%)
Jun 2023
-
$1.15B(+23.6%)
Mar 2023
-
$934.08M(-7.4%)
Dec 2022
$1.01B(+94.3%)
$1.01B(+29.6%)
Sep 2022
-
$777.86M(+1.5%)
Jun 2022
-
$766.44M(+18.4%)
Mar 2022
-
$647.20M(+24.7%)
Dec 2021
$518.99M
$518.99M(-48.2%)
Sep 2021
-
$1.00B(-22.4%)
Jun 2021
-
$1.29B(-6.3%)
DateAnnualQuarterly
Mar 2021
-
$1.38B(-3.3%)
Dec 2020
$1.42B(+270.2%)
$1.42B(+64.5%)
Sep 2020
-
$865.45M(+72.8%)
Jun 2020
-
$500.94M(-10.1%)
Mar 2020
-
$557.15M(+44.8%)
Dec 2019
$384.69M(-14.1%)
$384.69M(-14.1%)
Sep 2019
-
$447.69M(-0.4%)
Jun 2019
-
$449.43M(-1.5%)
Mar 2019
-
$456.29M(+1.8%)
Dec 2018
$448.05M(+13.3%)
$448.05M(+27.4%)
Sep 2018
-
$351.79M(+1.6%)
Jun 2018
-
$346.41M(-3.8%)
Mar 2018
-
$360.25M(-8.9%)
Dec 2017
$395.44M(+128.8%)
$395.44M(+122.0%)
Sep 2017
-
$178.09M(+3.0%)
Dec 2016
$172.85M(+477.1%)
$172.85M
Dec 2015
$29.95M
-

FAQ

  • What is Denali Therapeutics annual working capital?
  • What is the all time high annual working capital for Denali Therapeutics?
  • What is Denali Therapeutics annual working capital year-on-year change?
  • What is Denali Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Denali Therapeutics?
  • What is Denali Therapeutics quarterly working capital year-on-year change?

What is Denali Therapeutics annual working capital?

The current annual working capital of DNLI is $762.23M

What is the all time high annual working capital for Denali Therapeutics?

Denali Therapeutics all-time high annual working capital is $1.42B

What is Denali Therapeutics annual working capital year-on-year change?

Over the past year, DNLI annual working capital has changed by -$223.93M (-22.71%)

What is Denali Therapeutics quarterly working capital?

The current quarterly working capital of DNLI is $786.76M

What is the all time high quarterly working capital for Denali Therapeutics?

Denali Therapeutics all-time high quarterly working capital is $1.42B

What is Denali Therapeutics quarterly working capital year-on-year change?

Over the past year, DNLI quarterly working capital has changed by -$104.23M (-11.70%)
On this page